Early Access

10-KPeriod: FY2022

Apple Inc. Annual Report, Year Ended Sep 24, 2022

Filed October 28, 2022For Securities:AAPL

Summary

Apple Inc.'s 2022 10-K filing reveals a company demonstrating robust growth and financial strength, despite operating in a challenging global economic environment. Net sales increased by 8% year-over-year to $394.3 billion, primarily driven by strong performance in iPhone, Services, and Mac segments. The Services segment, in particular, continued its upward trajectory, showing a 14% increase in net sales, underscoring Apple's successful diversification beyond hardware. The company maintained healthy gross margins, with a total gross margin of 43.3%, and a significant increase in operating income, reflecting effective cost management and operational efficiency. While Apple continues to innovate and introduce new products across its portfolio, the company acknowledges significant risks, including macroeconomic headwinds, supply chain disruptions, intense competition, and evolving regulatory landscapes globally. However, Apple's substantial cash reserves, ongoing share repurchase program, and dividend payments indicate a strong commitment to returning value to shareholders. The company's financial position remains solid, supported by diversified revenue streams and a focus on innovation, positioning it to navigate potential future challenges.

Financial Statements
Beta

Key Highlights

  • 1Total net sales grew 8% to $394.3 billion in fiscal year 2022, driven by iPhone, Services, and Mac.
  • 2The Services segment saw a significant 14% increase in net sales, reaching $78.1 billion, highlighting its growing importance.
  • 3Gross margin improved to 43.3% from 41.8% in the prior year, with notable increases in both Product and Services gross margins.
  • 4Operating income increased by $10.5 billion to $119.4 billion, reflecting strong operational performance.
  • 5Apple continued its robust capital return program, repurchasing $90.2 billion of common stock and paying $14.8 billion in dividends and dividend equivalents.
  • 6Significant investment in Research and Development continued, with R&D expenses increasing by 20% to $26.3 billion.
  • 7Despite global economic uncertainties and supply chain risks, the company ended the fiscal year with substantial liquidity, holding $156.4 billion in cash, cash equivalents, and unrestricted marketable securities.

Frequently Asked Questions